An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Treatment Acquiring Traction Online
Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.
Active Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with numerous of members share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Experts Voice Concerns
However, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.
Some experts stated the demand for the experimental drug could be linked to the rising cost of approved slimming products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the British medical regulations.
Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Material Elimination
Based on the social media company, the service has taken down violative content and prohibited associated keywords and query recommendations. The company said it was committed to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Digital Trading Activities
Research also found communities with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of users, populated with images of slimming results, positive reviews and step-by-step guides for preparing or administering at home.
After minutes of entering one group, a vendor posted contact information, where the majority of purchases take place. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.
Product Details and Costs
Inside these communities, messages show dark colored packages with postal service stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When asked how long a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service stated it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to potentially serious medical dangers”.
